Advances in Treatment of Colorectal Neuroendocrine Tumors

Chang-xian CHEN; Li-ju ZHANG; Xiao-ming JIANG; Zhen-yong ZHANG; Wei-jun LIU

doi:10.12259/j.issn.2095-610X.S20201242

Volume 41 Issue 12

Dec. 2019

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2020 > 41(12): 155-159

Chang-xian CHEN, Li-ju ZHANG, Xiao-ming JIANG, Zhen-yong ZHANG, Wei-jun LIU. Advances in Treatment of Colorectal Neuroendocrine Tumors[J]. Journal of Kunming Medical University, 2020, 41(12): 155-159. doi: 10.12259/j.issn.2095-610X.S20201242

Citation:

Chang-xian CHEN, Li-ju ZHANG, Xiao-ming JIANG, Zhen-yong ZHANG, Wei-jun LIU. Advances in Treatment of Colorectal Neuroendocrine Tumors[J]. Journal of Kunming Medical University, 2020, 41(12): 155-159. doi: 10.12259/j.issn.2095-610X.S20201242

Citation:

PDF( 553 KB)

Advances in Treatment of Colorectal Neuroendocrine Tumors

doi: 10.12259/j.issn.2095-610X.S20201242

Dept. of Anorectal Diseases，Medical School & Affiliated Hospital Kunming University of Science and Technology，Kunming Yunnan 650032，China

Received Date: 2020-02-29
Publish Date: 2019-12-26

Abstract

Abstract

Colorectal neuroendocrine tumors were previously considered to be very rare intestinal tumors. However, with the raising of people's awareness of physical examination and the popularity of colonoscopy, the number of cases detected has been increasing rapidly. Colorectal neuroendocrine tumors are mostly inert tumors with no special symptoms; patient is not aware of it, so these tumors are easily missed or even misdiagnosed by less experienced doctors. The treatment of this disease relies more on surgical treatment. Many new technologies have been developed in recent years, such as minimally invasive technology, bio-therapy, targeted therapy. It is the common demand of both doctors and patients to reduce the incidence of complications on the basis of improving therapeutic effect. Making the diagnosis and treatment of this disease requires more attention and research by surgeons.
- Colorectal neuroendocrine tumors,
- Chemoradiotherapy,
- Surgery,
- Prognosis

FullText(HTML)

References(35)

References

[1]	Dasari A,Shen C,Halperin D,et al. Trends in the incidence,prevalence,and survival outcomes in patients with neuroendocrine tumors in the united states[J]. JAMA Oncol,2017,3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589
[2]	Bustamante-Lopez L A,Nahas S C,Nahas C S R,et al. Is there a difference between right- versus left-sided colon cancers? Does side make any difference in long-term follow-up?[J]. Arq Bras Cir Dig,2019,32(4):e1479. doi: 10.1590/0102-672020190001e1479
[3]	Chaoyong Shen1,Yuan Yin,Huijiao Chen,et al. Neuroendocrine tumors of colon and rectum:Validation of clinical and prognostic values of the world health organization 2010 grading classifications and european neuroendocrine tumor society staging systems[J]. Oncotarget,2017,28(13):22123-22134.
[4]	朱雄增. 胃肠胰神经内分泌肿瘤新分类的临床意义[J].中华胃肠外科杂志,2013,16(1):12-14. doi: 10.3760/cma.j.issn.1671-0274.2013.01.004
[5]	Turaga K K,Kvols L K. Recent progress in the understanding,diagnosis,and treatment of gastroenteropancreatic neuroendocrine tumors[J]. CA Cancer J Clin,2011,61(2):113-132. doi: 10.3322/caac.20097
[6]	李洁,孙宇,吴佳怿. 胰腺和胃肠道来源神经内分泌肿瘤分类—2018 IARC/WHO分类框架共识解读[J].肿瘤综合治疗电子杂志,2018,4(4):16-20.
[7]	Anthony L B,Strosberg J R,Klimstra D S,et al. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors(nets):Well-differentiated nets of the distal colon and rectum[J]. Pancreas,2010,39(6):767-774. doi: 10.1097/MPA.0b013e3181ec1261
[8]	袁华燕,程勇. 结直肠神经内分泌癌的诊疗进展[J].中外医疗,2019,38(10):195-198.
[9]	郑楚伊,施永恒,刘强,等. 113例直肠神经内分泌肿瘤的临床病理观察[J].上海交通大学学报(医学版),2019,39(3):297-303.
[10]	徐建明,梁后杰,秦叔逵,等. 中国胃肠胰神经内分泌肿瘤专家共识(2016年版)[J].临床肿瘤学杂志,2016,21(10):927-946.
[11]	石光锋,王晓霜. 直肠神经内分泌肿瘤的微创治疗[J].世界最新医学信息文摘,2016,16(95):70.
[12]	杨根源,郭晓红,施茜,等. 结扎装置辅助内镜下黏膜下层切除术与黏膜下层剥离术治疗直肠神经内分泌肿瘤的对照研究[J].胃肠病学和肝病学杂志,2016,25(2):155-158.
[13]	朱建华,郝凤媛,李楠. 直肠神经内分泌肿瘤内镜下诊疗的临床研究[J].中华保健医学杂志,2019,21(1):42-44.
[14]	Wang X,Xiang L,Li A,et al. Endoscopic submucosal dissection for the treatment of rectal carcinoid tumors 7-16 mm in diameter[J]. Int J Colorectal Dis,2015,30(3):375-380. doi: 10.1007/s00384-014-2117-2
[15]	Zhang D G,Luo S,Xiong F,et al. Endoloop ligation after endoscopic mucosal resection using a transparent cap:A novel method to treat small rectal carcinoid tumors[J]. World J Gastroenterol,2019,25(10):1259-1265. doi: 10.3748/wjg.v25.i10.1259
[16]	张莉,王李心,王国芬,等. EMR-C及ESD在直肠神经内分泌肿瘤治疗中的应用效果比较[J].结直肠肛门外科,2018,24(4):389-392.
[17]	中国胃肠胰神经内分泌肿瘤病理专家组. 中国胃肠胰神经内分泌肿瘤病理学诊断共识[J].中华病理学杂志,2011,40(4):257-262. doi: 10.3760/cma.j.issn.0529-5807.2011.04.010
[18]	任春成,李非,陈希琳,等. 经肛门内镜微创切除术治疗直肠神经内分泌肿瘤的疗效观察[J].结直肠肛门外科,2019,25(3):333-336.
[19]	姜鹏,张宏,丛进春,等. 腹腔镜与经肛门内镜微创手术切除直肠神经内分泌肿瘤的短期疗效比较[J].中国医刊,2018,53(11):1236-1240. doi: 10.3969/j.issn.1008-1070.2018.11.008
[20]	陈洛海,陈洁,周志伟. 胃肠道神经内分泌肿瘤治疗最新指南解读[J].中华胃肠外科杂志,2016,19(11):1201-1204. doi: 10.3760/cma.j.issn.1671-0274.2016.11.001
[21]	Hyde A J,Nassabein R,AlShareef A,et al. Eastern canadian gastrointestinal cancer consensus conference 2018[J]. Curr Oncol,2019,26(5):e665-e681.
[22]	戴广海,千年松. 胃肠胰神经内分泌肿瘤多学科综合治疗协作组诊疗模式专家共识[J].中国实用外科杂志,2017,37(1):46-47,66.
[23]	吴爽,韩宇. 胃肠胰神经内分泌肿瘤药物治疗进展[J].中国肿瘤临床,2018,45(8):422-426. doi: 10.3969/j.issn.1000-8179.2018.08.144
[24]	Garcia-Carbonero R,Rinke A,Valle J W,et al. ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms. Systemic therapy 2:Chemotherapy[J]. Neuroendocrinology,2017,105(3):281-294. doi: 10.1159/000473892
[25]	王麒宇,王亚旭. 结直肠神经内分泌肿瘤的治疗进展[J].世界最新医学信息文摘,2019,19(99):137-138,140.
[26]	Reuther C,Heinzle V,Nolting S,et al. The HDM2(MDM2)inhibitor NVP-CGM097 inhibits tumor cell proliferation and shows additive effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 cascade in the p53wild type neuroendocrine tumor cell line GOT1[J]. Neuroendocrinology,2018,106(1):1-19. doi: 10.1159/000453369
[27]	裴效瑞,张权,卢德宝. 胃肠道神经内分泌肿瘤患者的药物治疗进展[J].医疗装备,2018,31(21):202-204. doi: 10.3969/j.issn.1002-2376.2018.21.142
[28]	Sorbye H,Kong G,Grozinsky-Glasberg S. PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms(WHO G3)[J]. Endocr Relat Cancer,2019,27(3):67-77.
[29]	勾贺,孟宇,宋敏. 神经内分泌肿瘤内科治疗的研究进展[J].河南医学研究,2019,28(9):1727-1729. doi: 10.3969/j.issn.1004-437X.2019.09.105
[30]	Lee L,Ito T,Jensen R T. Everolimus in the treatment of neuroendocrine tumors:Efficacy,side-effects,resistance,and factors affecting its place in the treatment sequence[J]. Expert Opin Pharmacother,2018,19(8):909-928. doi: 10.1080/14656566.2018.1476492
[31]	Wang Z J,An K,Li R,et al. Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals[J]. World J Gastroenterol,2019,25(34):5197-5209. doi: 10.3748/wjg.v25.i34.5197
[32]	范振列,杨召,乔友林,等. 109例直肠神经内分泌肿瘤患者的临床病理特征与预后分析[J].中国肿瘤,2017,26(4):308-314.
[33]	宋宝荣,张霞,徐烨,等. 婚姻状态对结直肠神经内分泌肿瘤患者远期预后的影响[J].同济大学学报(医学版),2017,38(4):81-85,92.
[34]	黄玉庭,贾茹,徐倩,等. 不同分期结肠与直肠神经内分泌肿瘤的预后分析[J].中华肿瘤杂志,2019,41(2):146-151. doi: 10.3760/cma.j.issn.0253-3766.2019.02.013
[35]	Man D,Wu J,Shen Z,et al. Prognosis of patients with neuroendocrine tumor:A SEER database analysis[J]. Cancer Manag Res,2018,10(1):5629-3568.

Relative Articles(20)

Relative Articles

[1]	Ruiting ZHANG, Bin YAN, Zuyan LI, Jinmin SUN, Jin YAO. Relations between Peripheral Blood Blast Clearance Time and Albumin Level at Initial Diagnosis during Induction Chemotherapy and Genetic Mutations and Prognosis in Patients with Acute Myeloid Leukemia. Journal of Kunming Medical University, 2024, 45(8): 117-124. doi: 10.12259/j.issn.2095-610X.S20240817
[2]	Bowen TAN, Yun LIANG, Huan CHEN, Yi LEI, Yuhan WANG, Yan TIAN. The Prognostic Value of Preoperative Peripheral Blood Inflammatory Markers Combined with Tumor Markers in Resectable Colon Cancer Patients. Journal of Kunming Medical University, 2024, 45(12): 1-5.
[3]	Chunyan LIU, Bingqing CHANG, Chao LI, Xin REN, Xiaoqin LIU. The Relationship between T Lymphocyte Subsets and Pathological Characteristics of Acute Myeloid Leukemia and the Value of Predicting Chemotherapy Prognosis. Journal of Kunming Medical University, 2024, 45(5): 116-122. doi: 10.12259/j.issn.2095-610X.S20240518
[4]	Xinyi MEN, Jing ZHAO, Yongchun SHEN, Hui JI, Xiuxia WANG. The Relationship between Peripheral Blood Immunoglobulin，Erythrocyte Sedimentation Rate，Homocysteine and the Degree of Central Nervous System Vasculitis in Children and Their Influence on Prognosis. Journal of Kunming Medical University, 2024, 45(12): 1-7.
[5]	Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA，CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135. doi: 10.12259/j.issn.2095-610X.S20230927
[6]	Jing LI, Lin WANG, Qiang KANG, Yuehua LI, Hong ZHU, Yixuan CHEN, Xuefen LEI. Analysis of Clinical Diagnosis and Treatment of Nonfunctional Pancreatic Neuroendocrine Neoplasms. Journal of Kunming Medical University, 2023, 44(7): 47-51. doi: 10.12259/j.issn.2095-610X.S20230706
[7]	Houji GUO, Mei YANG, Zhongwei QIN, Zhanyi HUANG. Correlation of Preoperative Anemia Types with Pathological Features and Prognosis in Patients with Colorectal Cancer. Journal of Kunming Medical University, 2023, 44(12): 165-170. doi: 10.12259/j.issn.2095-610X.S20231226
[8]	Yaping JIANG, Hongying YANG, Haohan WANG, Xianling Ning, Xielan YANG. Effect of Different Intestinal Surgical Methods on Prognosis of Patients with Intestinal Invasive Epithelial Ovarian Cancer. Journal of Kunming Medical University, 2023, 44(1): 85-90. doi: 10.12259/j.issn.2095-610X.S20230109
[9]	Ruijuan MA, Feng ZHANG, Ruiting ZHANG, Jin YAO. Effect of Hematopoietic Function Recovery and MRD Status after Induction Chemotherapy on the Prognosis of Patients with Newly Diagnosed Acute Myeloid Leukemia. Journal of Kunming Medical University, 2022, 43(5): 88-94. doi: 10.12259/j.issn.2095-610X.S20220512
[10]	Yan WANG, Rong DING, Lvling ZHANG, Ruohua WANG, Xiaoling ZHAO, Na MA. Efficacy of Blood Transfusion Combined with Chemoradiotherapy in Patients with Colorectal Cancer and its Effect on Tumor Markers and T Lymphocyte Levels. Journal of Kunming Medical University, 2022, 43(8): 61-65. doi: 10.12259/j.issn.2095-610X.S20220809
[11]	Ma Lin . . Journal of Kunming Medical University,
[12]	Sun Heng . . Journal of Kunming Medical University,
[13]	Li Xiao Kai . . Journal of Kunming Medical University,
[14]	Zhang Mei Qiong . . Journal of Kunming Medical University,
[15]	Shi Lei . . Journal of Kunming Medical University,
[16]	Wang Chong Qian . . Journal of Kunming Medical University,
[17]	Yin Liang . . Journal of Kunming Medical University,
[18]	Yang Jie . . Journal of Kunming Medical University,
[19]	. . Journal of Kunming Medical University,
[20]	. . Journal of Kunming Medical University,